Global Methimazole API Market Research Report 2025

Publication ID:

PB503263624

Publication Date:

March 24, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Methimazole API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Methimazole API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methimazole API.
The Methimazole API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Methimazole API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methimazole API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CU CHEMIE UETIKON GMBH
MACLEODS PHARMACEUTICALS LTD
MAITHRI DRUGS PRIVATE LTD
Beijing Taiyang Pharmaceutical Co., Ltd.
Beijing Beiwei Pharmaceutical Co., Ltd.
Beijing Tongjida Pharmaceutical Co., Ltd.
Guizhou Shengjitang Pharmaceutical Co., Ltd.
by Type
笔耻谤颈迟测鈮�99%
Purity<99%
by Application
Tablets
Cream
Enteric-coated Tablets
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Methimazole API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Methimazole API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Methimazole API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Methimazole API Market Overview
1.1 Product Definition
1.2 Methimazole API by Type
1.2.1 Global Methimazole API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 笔耻谤颈迟测鈮�99%
1.2.3 Purity<99%
1.3 Methimazole API by Application
1.3.1 Global Methimazole API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Cream
1.3.4 Enteric-coated Tablets
1.4 Global Market Growth Prospects
1.4.1 Global Methimazole API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Methimazole API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Methimazole API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Methimazole API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Methimazole API Production Market Share by Manufacturers (2020-2025)
2.2 Global Methimazole API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Methimazole API, Industry Ranking, 2023 VS 2024
2.4 Global Methimazole API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Methimazole API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Methimazole API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Methimazole API, Product Offered and Application
2.8 Global Key Manufacturers of Methimazole API, Date of Enter into This Industry
2.9 Methimazole API Market Competitive Situation and Trends
2.9.1 Methimazole API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Methimazole API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Methimazole API Production by Region
3.1 Global Methimazole API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Methimazole API Production Value by Region (2020-2031)
3.2.1 Global Methimazole API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Methimazole API by Region (2026-2031)
3.3 Global Methimazole API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Methimazole API Production Volume by Region (2020-2031)
3.4.1 Global Methimazole API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Methimazole API by Region (2026-2031)
3.5 Global Methimazole API Market Price Analysis by Region (2020-2025)
3.6 Global Methimazole API Production and Value, Year-over-Year Growth
3.6.1 North America Methimazole API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Methimazole API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Methimazole API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Methimazole API Production Value Estimates and Forecasts (2020-2031)
4 Methimazole API Consumption by Region
4.1 Global Methimazole API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Methimazole API Consumption by Region (2020-2031)
4.2.1 Global Methimazole API Consumption by Region (2020-2025)
4.2.2 Global Methimazole API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Methimazole API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Methimazole API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Methimazole API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Methimazole API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Methimazole API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Methimazole API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Methimazole API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Methimazole API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Methimazole API Production by Type (2020-2031)
5.1.1 Global Methimazole API Production by Type (2020-2025)
5.1.2 Global Methimazole API Production by Type (2026-2031)
5.1.3 Global Methimazole API Production Market Share by Type (2020-2031)
5.2 Global Methimazole API Production Value by Type (2020-2031)
5.2.1 Global Methimazole API Production Value by Type (2020-2025)
5.2.2 Global Methimazole API Production Value by Type (2026-2031)
5.2.3 Global Methimazole API Production Value Market Share by Type (2020-2031)
5.3 Global Methimazole API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Methimazole API Production by Application (2020-2031)
6.1.1 Global Methimazole API Production by Application (2020-2025)
6.1.2 Global Methimazole API Production by Application (2026-2031)
6.1.3 Global Methimazole API Production Market Share by Application (2020-2031)
6.2 Global Methimazole API Production Value by Application (2020-2031)
6.2.1 Global Methimazole API Production Value by Application (2020-2025)
6.2.2 Global Methimazole API Production Value by Application (2026-2031)
6.2.3 Global Methimazole API Production Value Market Share by Application (2020-2031)
6.3 Global Methimazole API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 CU CHEMIE UETIKON GMBH
7.1.1 CU CHEMIE UETIKON GMBH Methimazole API Company Information
7.1.2 CU CHEMIE UETIKON GMBH Methimazole API Product Portfolio
7.1.3 CU CHEMIE UETIKON GMBH Methimazole API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 CU CHEMIE UETIKON GMBH Main Business and Markets Served
7.1.5 CU CHEMIE UETIKON GMBH Recent Developments/Updates
7.2 MACLEODS PHARMACEUTICALS LTD
7.2.1 MACLEODS PHARMACEUTICALS LTD Methimazole API Company Information
7.2.2 MACLEODS PHARMACEUTICALS LTD Methimazole API Product Portfolio
7.2.3 MACLEODS PHARMACEUTICALS LTD Methimazole API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 MACLEODS PHARMACEUTICALS LTD Main Business and Markets Served
7.2.5 MACLEODS PHARMACEUTICALS LTD Recent Developments/Updates
7.3 MAITHRI DRUGS PRIVATE LTD
7.3.1 MAITHRI DRUGS PRIVATE LTD Methimazole API Company Information
7.3.2 MAITHRI DRUGS PRIVATE LTD Methimazole API Product Portfolio
7.3.3 MAITHRI DRUGS PRIVATE LTD Methimazole API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 MAITHRI DRUGS PRIVATE LTD Main Business and Markets Served
7.3.5 MAITHRI DRUGS PRIVATE LTD Recent Developments/Updates
7.4 Beijing Taiyang Pharmaceutical Co., Ltd.
7.4.1 Beijing Taiyang Pharmaceutical Co., Ltd. Methimazole API Company Information
7.4.2 Beijing Taiyang Pharmaceutical Co., Ltd. Methimazole API Product Portfolio
7.4.3 Beijing Taiyang Pharmaceutical Co., Ltd. Methimazole API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Beijing Taiyang Pharmaceutical Co., Ltd. Main Business and Markets Served
7.4.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments/Updates
7.5 Beijing Beiwei Pharmaceutical Co., Ltd.
7.5.1 Beijing Beiwei Pharmaceutical Co., Ltd. Methimazole API Company Information
7.5.2 Beijing Beiwei Pharmaceutical Co., Ltd. Methimazole API Product Portfolio
7.5.3 Beijing Beiwei Pharmaceutical Co., Ltd. Methimazole API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Beijing Beiwei Pharmaceutical Co., Ltd. Main Business and Markets Served
7.5.5 Beijing Beiwei Pharmaceutical Co., Ltd. Recent Developments/Updates
7.6 Beijing Tongjida Pharmaceutical Co., Ltd.
7.6.1 Beijing Tongjida Pharmaceutical Co., Ltd. Methimazole API Company Information
7.6.2 Beijing Tongjida Pharmaceutical Co., Ltd. Methimazole API Product Portfolio
7.6.3 Beijing Tongjida Pharmaceutical Co., Ltd. Methimazole API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Beijing Tongjida Pharmaceutical Co., Ltd. Main Business and Markets Served
7.6.5 Beijing Tongjida Pharmaceutical Co., Ltd. Recent Developments/Updates
7.7 Guizhou Shengjitang Pharmaceutical Co., Ltd.
7.7.1 Guizhou Shengjitang Pharmaceutical Co., Ltd. Methimazole API Company Information
7.7.2 Guizhou Shengjitang Pharmaceutical Co., Ltd. Methimazole API Product Portfolio
7.7.3 Guizhou Shengjitang Pharmaceutical Co., Ltd. Methimazole API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Guizhou Shengjitang Pharmaceutical Co., Ltd. Main Business and Markets Served
7.7.5 Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Methimazole API Industry Chain Analysis
8.2 Methimazole API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Methimazole API Production Mode & Process Analysis
8.4 Methimazole API Sales and Marketing
8.4.1 Methimazole API Sales Channels
8.4.2 Methimazole API Distributors
8.5 Methimazole API Customer Analysis
9 Methimazole API Market Dynamics
9.1 Methimazole API Industry Trends
9.2 Methimazole API Market Drivers
9.3 Methimazole API Market Challenges
9.4 Methimazole API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

CU CHEMIE UETIKON GMBH
MACLEODS PHARMACEUTICALS LTD
MAITHRI DRUGS PRIVATE LTD
Beijing Taiyang Pharmaceutical Co., Ltd.
Beijing Beiwei Pharmaceutical Co., Ltd.
Beijing Tongjida Pharmaceutical Co., Ltd.
Guizhou Shengjitang Pharmaceutical Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂